Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.6.5 has been added to the page, replacing the former v3.6.4 version. The Plain Language Summary section has been removed.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a backend/content-management update.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.0 to Revision: v3.6.3 to reflect a newer version.SummaryDifference0.0%

- Check52 days agoChange DetectedBolzano's location entry has been updated to Bolzano, Trentino-Alto Adige, Italy, 39100, replacing the previous Bolzano entry listed under Trentino-Sudtirol. This reflects a regional naming update and provides the same city/address in the study's locations.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new published version of the study details page.SummaryDifference0.0%

- Check73 days agoChange DetectedThe Locations section updated the Bolzano entry: the region is now Trentino-Sudtirol (instead of Trentino-Alto Adige) and the listing reads Bolzano, Trentino-Sudtirol, Italy, 39100. This reflects a regional naming update and a more precise address for the site.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.